Michael Schiff
Impact in
- Rheumatology top 0.01%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
- Hematology top 0.2%
- Autoimmune and Inflammatory Disorders Research
Papers in
- Rheumatology 116
- Rheumatoid Arthritis Research and Therapies 106
- Systemic Lupus Erythematosus Research 18
- Spondyloarthritis Studies and Treatments 8
- Genetics 24
- Chronic Lymphocytic Leukemia Research 24
- Co-authors
- Yule Liu (11 shared papers)Savithramma P. Dinesh‐Kumar (10 shared papers)Roy Fleischmann (35 shared papers)Larry W. Moreland (12 shared papers)Edward Keystone (15 shared papers)Arthur L. Weaver (9 shared papers)Désirée van der Heijde (15 shared papers)Mark C. Genovese (12 shared papers)
- Journals
- Annals of the Rheumatic Diseases (38 papers)The Journal of Rheumatology (9 papers)Current Medical Research and Opinion (6 papers)RMD Open (5 papers)Arthritis Research & Therapy (5 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Michael Schiff
163 papers receiving 19.1k citations
Michael Schiff's Hit Papers
Peers
Comparison fields: 5 of 153
- Rheumatology 10.6k
- Hematology 3.0k
- Immunology 2.7k
- Plant Science 4.4k
- Genetics 1.1k
Countries citing papers authored by Michael Schiff
This map shows the geographic impact of Michael Schiff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Schiff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Schiff more than expected).
Fields of papers citing papers by Michael Schiff
This network shows the impact of papers produced by Michael Schiff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Schiff. The network helps show where Michael Schiff may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Schiff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 164 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis Hit paper breakdown → | 2000 | 1447 |
| 2 | Virus‐induced gene silencing in tomato Hit paper breakdown → | 2002 | 1373 |
| 3 | Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein Hit paper breakdown → | 1997 | 1338 |
| 4 | Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial Hit paper breakdown → | 2004 | 976 |
| 5 | Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor α Inhibition Hit paper breakdown → | 2005 | 972 |
| 6 | Tobacco Rar1, EDS1 and NPR1/NIM1 like genes are required for N‐mediated resistance to tobacco mosaic virus Hit paper breakdown → | 2002 | 889 |
| 7 | A simplified disease activity index for rheumatoid arthritis for use in clinical practice Hit paper breakdown → | 2003 | 822 |
| 8 | Autophagy Regulates Programmed Cell Death during the Plant Innate Immune Response Hit paper breakdown → | 2005 | 726 |
| 9 | Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial Hit paper breakdown → | 2006 | 689 |
| 10 | Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate Hit paper breakdown → | 2008 | 636 |
| 11 | Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two‐year radiographic and clinical outcomes Hit paper breakdown → | 2002 | 591 |
| 12 | Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin‐1 receptor antagonist, in combination with methotrexate: Results of a twenty‐four–week, multicenter, randomized, double‐blind, placebo‐controlled trial Hit paper breakdown → | 2002 | 527 |
| 13 | Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate Hit paper breakdown → | 2007 | 430 |
| 14 | Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial Hit paper breakdown → | 2008 | 420 |
| 15 | Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis). | 2003 | 418 |
| 16 | 2006 | 361 | |
| 17 | Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease‐Modifying Antirheumatic Drug Treatment Hit paper breakdown → | 2016 | 317 |
| 18 | 2003 | 302 | |
| 19 | 2004 | 297 | |
| 20 | 2011 | 295 |
About Michael Schiff
Michael Schiff is a scholar working on Rheumatology, Genetics, Pathology and Forensic Medicine, Hematology and Plant Science, having authored 164 papers that have together received 20.2k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (106 papers), Chronic Lymphocytic Leukemia Research (24 papers), Systemic Lupus Erythematosus Research (18 papers), Lymphoma Diagnosis and Treatment (15 papers), Autoimmune and Inflammatory Disorders Research (14 papers), Plant Virus Research Studies (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Spondyloarthritis Studies and Treatments (8 papers). The work is most often cited by research in Rheumatology (10.6k citations), Hematology (3.0k citations), Immunology (2.7k citations), Plant Science (4.4k citations) and Genetics (1.1k citations). Michael Schiff has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Yule Liu, Savithramma P. Dinesh‐Kumar, Roy Fleischmann, Larry W. Moreland, Edward Keystone, Arthur L. Weaver, Désirée van der Heijde, Mark C. Genovese, Rajendra Marathe and Joan M. Bathon. Their work appears in journals such as Annals of the Rheumatic Diseases, The Journal of Rheumatology, Current Medical Research and Opinion, RMD Open and Arthritis Research & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.